Coherus Announces BLA Filing for Lucentis® (ranibizumab) Biosimilar Candidate Accepted by FDA for Review

NEXT STORY
American Gene Technologies Appoints Dr. Marcus A. Conant as Special Advisor to the CEO
PREV STORY
New to The Street / Newsmax TV Announces 8 Interviews for this Week’s TV Broadcast, October 3, 2021, airing at 10-11 AM ET
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Idera Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update

CAMBRIDGE, Mass. and EXTON, Pa., May 04, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. ...

author_avatar
NASDAQ Market News

Crescendo Bioscience Highlights New Studies With Vectra(R) DA That Will Be Presented at the American College of Rheumatology 2015 Annual Meeting

SALT LAKE CITY, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary ...

author_avatar
NASDAQ Market News

Athenex, Inc. Announces Pricing of Offering of Common Stock

BUFFALO, N.Y., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Athenex (Nasdaq:ATNX), a global biopharmaceutical company ...

author_avatar
NASDAQ Market News